Name
Purdue University Globle
NU505 Clinical Epidemiology and Population Health Promotion
Prof. Name
Date
Immunity protects the body from harmful pathogens, while vaccination prepares the immune system to recognize and respond to specific infections before they cause serious disease. Vaccines are among the most effective public health interventions because they reduce preventable infections, severe illness, hospitalizations, and deaths while also limiting transmission within communities. Staying up to date with recommended immunizations and using reliable, evidence-based vaccine information can help individuals make informed healthcare decisions and support population health.
Vaccination has changed modern healthcare by dramatically reducing the impact of diseases that once caused widespread illness and death. Immunization protects vaccinated individuals, helps shield people who cannot be vaccinated, and reduces pressure on healthcare systems. Understanding how immunity works, how vaccines provide protection, and the legal, ethical, socioeconomic, and cultural factors that affect vaccination decisions is important for patients, families, healthcare professionals, and public health programs.
Immunity is the body’s ability to recognize and defend against harmful microorganisms, including viruses, bacteria, and other pathogens. The immune system uses specialized cells, antibodies, and immune memory to identify threats and coordinate an appropriate response.
Immunity can develop through exposure to a pathogen or through vaccination. It is generally divided into active immunity and passive immunity, which differ in how protection is acquired and how long it typically lasts.
Active immunity develops when a person’s immune system produces its own immune response after encountering an antigen. This can happen following an infection or vaccination. Because active immunity can create immune memory, protection may persist for a long period, although its duration varies depending on the disease, vaccine, and individual.
Two major forms of active immunity are:
Natural active immunity: Develops after a person becomes infected and mounts an immune response.
Vaccine-induced active immunity: Develops after vaccination exposes the immune system to an antigen in a way designed to stimulate protection without requiring the person to experience the disease itself.
Vaccination is an important way to develop disease-specific immune protection without taking the risks associated with contracting many potentially serious infections.
Passive immunity occurs when antibodies are transferred to a person from another source. It can provide protection quickly, but the protection is generally temporary because the recipient’s immune system does not produce the transferred antibodies itself.
Examples include antibodies transferred:
From a pregnant person to a fetus through the placenta.
Through breast milk after birth.
Through immune globulin or other antibody-containing products used in certain medical situations.
The key difference is that active immunity is generated by the person’s own immune system, whereas passive immunity is received from another source.
Immunization is a cornerstone of preventive healthcare. Vaccines help prevent infectious diseases before exposure or reduce the likelihood of severe disease after exposure, depending on the specific vaccine and infection.
Recommended vaccines can provide substantial protection against serious infectious diseases. Vaccination can reduce the risk of complications, hospitalization, disability, and death associated with vaccine-preventable illnesses.
Vaccination is particularly important for people who may face greater risks from infectious diseases, including infants, older adults, pregnant individuals, and people with certain medical conditions.
Vaccines can also reduce the number of infections circulating in a population, which provides benefits beyond the individual who receives the vaccine.
When vaccination coverage is sufficiently high, transmission of some infectious diseases can decrease. This is commonly described as community immunity or herd immunity. It can provide indirect protection to people who are not eligible for particular vaccines or who may not develop adequate immunity after vaccination.
Community vaccination programs can contribute to:
Fewer outbreaks and infections.
Lower rates of severe disease.
Reduced pressure on healthcare services.
Protection of vulnerable populations.
Greater public health preparedness.
The level of vaccination needed to achieve substantial community protection varies by disease because pathogens differ in their transmissibility and other characteristics.
Vaccination has had a profound effect on global health. The World Health Organization (WHO) reported in 2024 that global immunization efforts have saved at least 154 million lives over the past 50 years, highlighting the enormous contribution of vaccines to disease prevention.
The WHO also reported that immunization accounts for approximately 40% of the observed reduction in infant deaths globally over that period. These findings demonstrate why maintaining and expanding access to routine immunization remains an important global health priority.
Vaccination programs can also provide economic benefits by preventing illness, reducing healthcare utilization, and helping people remain healthy enough to attend school and work.
Vaccination decisions are influenced by more than vaccine availability. Access, confidence, communication, social conditions, previous healthcare experiences, and cultural beliefs can all affect whether people receive recommended vaccines.
People may miss recommended vaccinations when healthcare services are difficult to access. Barriers can include transportation problems, financial limitations, lack of insurance or healthcare coverage, geographic isolation, limited clinic availability, and inadequate health information.
Improving vaccination rates therefore requires more than educating individuals. Public health programs may also need to address practical barriers that make vaccination difficult to obtain.
Vaccine hesitancy refers to delayed acceptance or refusal of vaccination despite vaccination services being available. It can have multiple causes and should not be assumed to result from a single belief or source of information.
Common influences include concerns about safety, fear of adverse effects, misinformation, distrust, personal experiences, cultural perspectives, and uncertainty about the benefits of vaccination.
Healthcare professionals can help address vaccine concerns by listening without judgment, explaining benefits and risks clearly, correcting misinformation, and using trustworthy evidence.
Trust can strongly influence vaccination decisions. Patients may be more receptive to vaccination recommendations when they have confidence in their healthcare professionals and public health institutions.
Building trust requires consistent communication, transparency about vaccine benefits and potential adverse effects, respect for patient concerns, and equitable access to healthcare.
Vaccines undergo extensive evaluation before authorization or approval and continue to be monitored after they are introduced into routine use. Safety monitoring systems help identify potential adverse events and evaluate whether they are actually caused by a vaccine.
Like other medical interventions, vaccines can cause side effects. Most vaccine-related reactions are mild and temporary, while serious adverse events are uncommon. The risks and benefits of an individual vaccine should be considered in relation to the disease it is designed to prevent.
No. High-quality scientific evidence does not support a causal relationship between vaccines and autism spectrum disorder. Large epidemiological studies conducted in different populations have consistently failed to establish vaccines as a cause of autism.
The original claim linking vaccination with autism has been extensively investigated and discredited.
Guillain-Barré syndrome (GBS) is a rare neurological disorder that can occur after certain infections. Research has identified a very small potential increased risk of GBS after some vaccines, depending on the vaccine and circumstances.
Importantly, the risk of GBS following vaccination is generally very low, and some infections themselves are associated with a greater risk of GBS. Vaccine-specific safety information should therefore be considered when discussing this rare complication.
Some vaccines are specifically recommended during pregnancy because vaccination can protect the pregnant person and provide protection to the newborn. Other vaccines may be avoided during pregnancy depending on their type and the individual’s circumstances.
Vaccination decisions during pregnancy should be based on current recommendations, gestational age, medical history, exposure risk, and advice from a qualified healthcare professional.
Current scientific evidence does not demonstrate that routine childhood vaccination causes Sudden Infant Death Syndrome (SIDS). Studies have not established a causal relationship between vaccination and SIDS.
Because SIDS can occur during the same age period when infants receive several routine vaccines, temporal association does not mean that vaccination caused the event.
Vaccination schedules are designed to provide protection when children are most vulnerable to particular infections. Recommendations can change as new evidence, vaccines, disease patterns, and public health guidance evolve.
Parents and caregivers should use the current immunization schedule published by the appropriate national health authority, such as the CDC in the United States, rather than relying on an older schedule.
Depending on age and individual circumstances, childhood immunization may include vaccines protecting against:
Hepatitis B
Rotavirus
Diphtheria, tetanus, and pertussis
Haemophilus influenzae type b
Polio
Pneumococcal disease
Measles, mumps, and rubella
Varicella
Hepatitis A
Influenza
The exact timing and number of doses depend on the vaccine and the child’s age, previous vaccination history, health conditions, and applicable national recommendations.
Children may receive additional doses or booster vaccinations as they grow. Catch-up vaccination can also be used when a child has missed recommended doses.
Annual influenza vaccination is recommended for many children, while other vaccines are administered according to age-specific schedules.
Adolescent immunization commonly includes vaccination against HPV, meningococcal disease, and tetanus, diphtheria, and pertussis, along with annual influenza vaccination where recommended.
Additional vaccines may be recommended based on medical conditions, travel, outbreaks, occupation, or other risk factors.
Vaccination laws vary considerably between countries, states, and other jurisdictions. Legal requirements may apply to school attendance, healthcare employment, childcare, or specific public health circumstances.
Depending on the jurisdiction, policies may address:
Required childhood or school immunizations.
Healthcare worker vaccination requirements.
Medical exemptions.
Religious or other exemptions where legally permitted.
Vaccine injury compensation programs.
Public health measures during outbreaks.
Because immunization laws can change, individuals should consult current government or public health guidance for the jurisdiction in which they live, work, or attend school.
Vaccination involves several ethical principles, including individual autonomy, prevention of harm, protection of vulnerable populations, fairness, and informed decision-making.
Vaccine equity means ensuring that people have fair opportunities to receive recommended vaccines regardless of income, geography, or social circumstances. Unequal access can allow preventable diseases to disproportionately affect underserved populations.
Efforts to improve vaccine equity may include community vaccination programs, accessible clinics, public education, outreach, and strategies that address transportation and financial barriers.
Vaccination mandates can create ethical debates because they involve balancing individual choice with broader public health responsibilities. Governments, schools, and healthcare organizations may establish vaccination requirements when they determine that vaccination is necessary to reduce risks to others.
The legal authority and specific requirements for mandates vary by jurisdiction and setting.
Healthcare professionals have an ethical responsibility to provide patients with understandable and accurate information about recommended vaccines. Effective informed consent includes discussing expected benefits, common adverse effects, relevant risks, alternatives when applicable, and the consequences of remaining unvaccinated.
Cultural beliefs and social experiences can influence how individuals understand disease prevention and vaccination. Decisions may be shaped by religious beliefs, family traditions, community attitudes, historical experiences with healthcare institutions, and preferences for conventional or traditional healthcare practices.
Culturally responsive communication can improve conversations about vaccination. Rather than dismissing concerns, healthcare professionals should listen carefully, recognize differences in health beliefs, use clear language, and provide evidence-based information that is relevant to the patient’s circumstances.
Vaccination remains a highly effective strategy for preventing infectious diseases and reducing their health and economic consequences. Its benefits extend from individual protection to community-level disease control.
Maintaining high vaccination coverage requires several complementary strategies: ensuring access to vaccines, monitoring safety, communicating reliable information, addressing misinformation, building trust, and adapting immunization programs to the needs of different populations.
Continued vaccination also helps preserve progress against diseases that have become uncommon in many regions. When vaccination coverage falls, diseases that remain present elsewhere can spread more easily and cause outbreaks.
Vaccines stimulate the immune system to develop protection against specific diseases.
Active immunity develops through the person’s own immune response, while passive immunity comes from transferred antibodies.
Vaccination can reduce the risk of serious disease, complications, hospitalization, and death.
Community immunity can reduce transmission and help protect people who cannot receive certain vaccines.
Current evidence does not support vaccines as a cause of autism or SIDS.
Vaccine safety is evaluated before approval or authorization and monitored after vaccines are introduced.
Vaccine schedules are designed around age, risk, and the timing needed to provide effective protection.
Vaccine acceptance can be affected by access barriers, misinformation, trust, cultural beliefs, and previous healthcare experiences.
Vaccination recommendations can change, so current guidance from national public health authorities should be used.
Active immunity occurs when the body’s immune system produces its own response after infection or vaccination. Passive immunity occurs when antibodies are transferred from another source. Active immunity can provide longer-lasting protection because it can create immune memory, while passive immunity generally provides immediate but temporary protection.
Vaccines help prevent infectious diseases and reduce the risk of severe illness, complications, hospitalization, and death. High vaccination coverage can also reduce transmission and provide indirect protection to vulnerable members of the community.
Vaccines are rigorously evaluated before authorization or approval and continuously monitored for safety afterward. Most vaccine side effects are mild and temporary, while serious adverse reactions are rare. The benefits and risks should be considered for each vaccine and individual circumstance.
No. Extensive scientific research has found no credible evidence that vaccines cause autism spectrum disorder. Multiple large studies conducted across different populations have not established a causal association.
Some vaccines require multiple doses to produce a strong or sustained immune response. Booster doses may be needed to maintain protection as immunity changes over time or as children reach ages when additional protection is recommended.
Vaccine hesitancy can result from concerns about safety, misinformation, lack of confidence in healthcare institutions, cultural or personal beliefs, previous experiences, and barriers to accessing vaccination services. Respectful conversations with trusted healthcare professionals can help people evaluate concerns using reliable evidence.
Herd immunity, more accurately called community immunity, occurs when enough people in a population are immune to an infection that transmission is reduced. The level of immunity required varies by disease.
Yes. Vaccination is a lifelong health consideration. Adults may need vaccines or booster doses based on age, pregnancy, occupation, medical conditions, travel, previous vaccination history, and exposure risks. Examples include influenza, COVID-19, shingles, pneumococcal, and Tdap vaccination, depending on individual circumstances and current recommendations.
Agency for Healthcare Research and Quality. (2021). Safety of vaccines used for routine immunization of adults (including pregnant women) and children. https://effectivehealthcare.ahrq.gov/products/vaccine-safety/research-protocol
Boccalini, S. (2025). Value of vaccinations: A fundamental public health priority to be fully evaluated. Vaccines, 13(5), 479. https://doi.org/10.3390/vaccines13050479
Centers for Disease Control and Prevention. (2024). About common vaccine safety questions and concerns. https://www.cdc.gov/vaccine-safety/about/
Centers for Disease Control and Prevention. (2024). Guillain-Barré syndrome (GBS) and vaccines. https://www.cdc.gov/vaccine-safety/about/guillain-barre.html
Centers for Disease Control and Prevention. (2024). Health and economic benefits of routine childhood immunizations in the era of the Vaccines for Children Program—United States, 1994–2023. Morbidity and Mortality Weekly Report, 73. https://www.cdc.gov/mmwr/volumes/73/wr/mm7331a2.htm
Centers for Disease Control and Prevention. (2024). Immunity types. https://www.cdc.gov/vaccines/basics/immunity-types.html
Centers for Disease Control and Prevention. (2024). Sudden infant death syndrome (SIDS) and vaccines. https://www.cdc.gov/vaccine-safety/about/sids.html
Goldstein, N. D., & Suder, J. S. (2022). Towards eliminating nonmedical vaccination exemptions among school-age children. Delaware Journal of Public Health, 8(1), 84–88. https://doi.org/10.32481/djph.2022.03.014
Rodriguez, S., Haider, K., Patel, F., Thatigiri, G., Pope, B., Albana, J., Daulat, S. R., Madhivanan, P., & Krupp, K. (2024). Sociopolitical antecedents influencing COVID-19 vaccine uptake in Pima County, Arizona. Vaccine: X, 22, 100589. https://doi.org/10.1016/j.jvacx.2024.100589
Sáfadi, M. A. P. (2023). The importance of immunization as a public health instrument. Jornal de Pediatria, 99(Suppl. 1), S1–S3. https://doi.org/10.1016/j.jped.2022.12.003
Uğrak, U., Aksungur, A., Akyüz, S., Şen, H., & Seyhan, F. (2025). Understanding the rise of vaccine refusal: Perceptions, fears, and influences. BMC Public Health, 25(1), 2574. https://doi.org/10.1186/s12889-025-23754-5
World Health Organization. (2024). Global immunization efforts have saved at least 154 million lives over the past 50 years. https://www.who.int/news/item/24-04-2024-global-immunization-efforts-have-saved-at-least-154-million-lives-over-the-past-50-years
